AMI Investment Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

AMI Investment Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-2,050	Closed	-$969K	–	37
2014 Q1	$969K	Sell	2,050 -20,588	-91%	-$972K	0.82%	25
2013 Q4	$996K	Sell	22,638 -3,500	-13%	-$146K	0.87%	27
2013 Q3	$1.01M	Sell	26,138 -23,850	-48%	-$902K	0.75%	28
2013 Q2	$1.76M	Buy	+49,988	New	+$1.69M	1.61%	22

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AMI Investment Management's XPH Position: Q2 2014 in Review

AMI Investment Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2014, closing a stake of 2,050 shares — an estimated $969K sold.

AMI Investment Management first reported a position in XPH in Q2 2013 and held it in 4 quarters. The position peaked at $1.76M in Q2 2013. 69 funds tracked by Wall St. Rank hold XPH as of Q2 2014.

AMI Investment Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2014 after selling out during the quarter.
AMI Investment Management sold 2,050 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2014, an estimated $969K.
AMI Investment Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 4 quarters.
AMI Investment Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.76M in Q2 2013.
69 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2014.

Based on AMI Investment Management's 13F filing for Q2 2014, filed 12 Aug 2014.